• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 789-803 of 1,261 results

1130 Exhibit: Exhibit 1130 Novo Nordisk Annual Report 2011

Document IPR2023-00724, No. 1130 Exhibit - Exhibit 1130 Novo Nordisk Annual Report 2011 (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1134 Exhibit: Exhibit 1134 39th Orange Book

Document IPR2023-00724, No. 1134 Exhibit - Exhibit 1134 39th Orange Book (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1160 Exhibit: Exhibit 1160 Perkovic

Document IPR2023-00724, No. 1160 Exhibit - Exhibit 1160 Perkovic (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1176 Exhibit: Exhibit 1176 McPhillips

Document IPR2023-00724, No. 1176 Exhibit - Exhibit 1176 McPhillips (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1183 Exhibit: Exhibit 1183 US7762994

Document IPR2023-00724, No. 1183 Exhibit - Exhibit 1183 US7762994 (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

2362 Exhibit: EX2362 US Food Drug Administration, DrugsFDA, Diabeta®

Document IPR2023-00724, No. 2362 Exhibit - EX2362 US Food Drug Administration, DrugsFDA, Diabeta® (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2470 Exhibit: EX2470 Rybelsus Prescribing Information rev Jan 2020

Document IPR2023-00724, No. 2470 Exhibit - EX2470 Rybelsus Prescribing Information rev Jan 2020 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2439 Exhibit: EX2439 Jardiance® Prescribing Information rev Dec 2017

Document IPR2023-00724, No. 2439 Exhibit - EX2439 Jardiance® Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2502 Exhibit: EX2502 Novo Nordisk, Financial report for the period 1 January 2020...

Document IPR2023-00724, No. 2502 Exhibit - EX2502 Novo Nordisk, Financial report for the period 1 January 2020 to 31 March 2020 May 6, 2020 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2406 Exhibit: EX2406 Aurobindo, “Aurobindo Received FDA Approval for Saxaglipt...

Document IPR2023-00724, No. 2406 Exhibit - EX2406 Aurobindo, “Aurobindo Received FDA Approval for Saxagliptin Tablets, 25mg and 5mg,” httpswwwaurobindousacomnewsproduct newsaurobindo rec...

cite Cite Document
Analyze

2380 Exhibit: EX2380 Mayo Clinic, “A1C test,” httpswwwmayoclinicorgtests procedu...

Document IPR2023-00724, No. 2380 Exhibit - EX2380 Mayo Clinic, “A1C test,” httpswwwmayoclinicorgtests procedures a1c testaboutpac 20384643, last updated Dec 1, 2022 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

1092 Exhibit: Anstaett Declaration

Document IPR2023-00724, No. 1092 Exhibit - Anstaett Declaration (P.T.A.B. Dec. 18, 2023)

cite Cite Document
Analyze

1025 Exhibit: Glaesner 2010

Document IPR2023-00724, No. 1025 Exhibit - Glaesner 2010 (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1059 Exhibit: Murphy 2012

Document IPR2023-00724, No. 1059 Exhibit - Murphy 2012 (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

2107 Exhibit: EX2107 Ozempic FDA Approval Letter for sNDA March 28, 2022

Document IPR2023-00724, No. 2107 Exhibit - EX2107 Ozempic FDA Approval Letter for sNDA March 28, 2022 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 53 54 55 56 57 ... >>